DEUTSCHE BANK AG\ - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$629,475
+57.6%
27,452
+13.3%
0.00%
Q2 2023$399,471
+296.6%
24,225
+329.1%
0.00%
Q1 2023$100,725
-38.7%
5,6460.0%0.00%
Q4 2022$164,412
-93.7%
5,646
-97.5%
0.00%
-100.0%
Q1 2022$2,616,000
+879.8%
227,114
+748.9%
0.00%
Q4 2021$267,000
-23.3%
26,754
+0.4%
0.00%
Q3 2021$348,000
-40.5%
26,639
-10.8%
0.00%
Q2 2021$585,000
-29.9%
29,876
-23.8%
0.00%
Q1 2021$834,000
+7.6%
39,229
+50.5%
0.00%
Q4 2020$775,000
+85.0%
26,058
+34.8%
0.00%
Q3 2020$419,000
+4.5%
19,328
+7.3%
0.00%
Q2 2020$401,000
+152.2%
18,012
+72.5%
0.00%
Q1 2020$159,000
-67.9%
10,441
-51.7%
0.00%
Q4 2019$495,000
+243.8%
21,619
+222.4%
0.00%
Q3 2019$144,000
-48.9%
6,705
-48.1%
0.00%
Q2 2019$282,000
+9.3%
12,913
+36.1%
0.00%
Q1 2019$258,000
+98.5%
9,485
+94.8%
0.00%
Q4 2018$130,000
-97.8%
4,869
-97.6%
0.00%
-100.0%
Q3 2018$5,799,000
+82.6%
198,848
+95.6%
0.00%
+100.0%
Q2 2018$3,176,000
+1405.2%
101,648
+854.6%
0.00%
Q1 2018$211,000
-61.1%
10,648
-43.2%
0.00%
Q4 2017$542,00018,7330.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders